Donaldson GP, Chou WC, Manson AL, et al. Spatially distinct physiology of Bacteroides fragilis within the proximal colon of gnotobiotic mice. Nat Microbiol. 2020;5(5):746-756. doi:10.1038/s41564-020-0683-3
Ernst NH, Reeves AZ, Ramseyer JE, Lesser CF. High-Throughput Screening of Type III Secretion Determinants Reveals a Major Chaperone-Independent Pathway. mBio. 2018;9(3). doi:10.1128/mBio.01050-18
Hajian B, Scocchera E, Keshipeddy S, et al. Propargyl-Linked Antifolates Are Potent Inhibitors of Drug-Sensitive and Drug-Resistant Mycobacterium tuberculosis. PLoS One. 2016;11(8):e0161740. doi:10.1371/journal.pone.0161740
Mou X, Souter S, Du J, Reeves AZ, Lesser CF. Synthetic bottom-up approach reveals the complex interplay of effectors in regulation of epithelial cell death. Proc Natl Acad Sci U S A. 2018;115(25):6452-6457. doi:10.1073/pnas.1801310115
Koppel N, Bisanz JE, Pandelia ME, Turnbaugh PJ, Balskus EP. Discovery and characterization of a prevalent human gut bacterial enzyme sufficient for the inactivation of a family of plant toxins. Elife. 2018;7. doi:10.7554/eLife.33953
Carey AF, Rock JM, Krieger IV, et al. TnSeq of Mycobacterium tuberculosis clinical isolates reveals strain-specific antibiotic liabilities. PLoS Pathog. 2018;14(3):e1006939. doi:10.1371/journal.ppat.1006939
Tang W, Liu DR. Rewritable multi-event analog recording in bacterial and mammalian cells. Science. 2018;360(6385). doi:10.1126/science.aap8992
Wellington S, Hung DT. The Expanding Diversity of Mycobacterium tuberculosis Drug Targets. ACS Infect Dis. 2018;4(5):696-714. doi:10.1021/acsinfecdis.7b00255
Ni J, Shen TCD, Chen EZ, et al. A role for bacterial urease in gut dysbiosis and Crohn’s disease. Sci Transl Med. 2017;9(416). doi:10.1126/scitranslmed.aah6888
Pan D, Kobayashi A, Jiang P, et al. A major chromatin regulator determines resistance of tumor cells to T cell-mediated killing. Science. 2018;359(6377):770-775. doi:10.1126/science.aao1710